Price movement over the last 24 hours
Agilent Technologies Inc vs US Global Jets ETF — how do they compare? Agilent Technologies Inc trades at $128.87 (market cap $37.04B), while US Global Jets ETF trades at $31.74. The key difference: Agilent Technologies Inc pays a 0.78% dividend while US Global Jets ETF pays none, and US Global Jets ETF is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | JETS | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Sector/Thematic |
52-Week High | $157.20 | $33.34 |
52-Week Low | $110.24 | $23.12 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
JETS trades at $33.34, up 0.42% with a bullish technical outlook from moving averages but overbought RSI signals. The ETF faces headwinds from soaring airline fuel costs, which jumped 85% in May to $6.7 billion (Reuters, 2026-07-07), pressuring profitability across the sector. Recent news highlights industry challenges including engine maker delays and fare pressures, though falling oil prices offer some relief.
Outlook remains cautious due to cyclical risks and fuel volatility; the ETF provides diversified airline exposure but requires monitoring of margin compression. Investment opportunity hinges on oil price trends and travel demand recovery, with significant downside risk if cost pressures persist.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →